Advertisement
Canada markets closed

  • S&P/TSX

    24,822.54
    +132.06 (+0.53%)
     

  • S&P 500

    5,864.67
    +23.20 (+0.40%)
     

  • DOW

    43,275.91
    +36.86 (+0.09%)
     

  • CAD/USD

    0.7246
    -0.0004 (-0.05%)
     

  • CRUDE OIL

    69.34
    -1.33 (-1.88%)
     

  • Bitcoin CAD

    94,152.50
    -344.92 (-0.37%)
     

  • XRP CAD

    0.75
    -0.00 (-0.65%)
     

  • GOLD FUTURES

    2,736.40
    +28.90 (+1.07%)
     

  • RUSSELL 2000

    2,276.09
    -4.76 (-0.21%)
     

  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     

  • NASDAQ

    18,489.55
    +115.94 (+0.63%)
     

  • VOLATILITY

    18.03
    -1.08 (-5.65%)
     

  • FTSE

    8,358.25
    -26.88 (-0.32%)
     

  • NIKKEI 225

    38,981.75
    +70.56 (+0.18%)
     

  • CAD/EUR

    0.6666
    -0.0024 (-0.36%)
     

Pfizer: Q2 Earnings Snapshot

Associated Press Finance
·1 min read

NEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Tuesday reported second-quarter earnings of $41 million.

On a per-share basis, the New York-based company said it had profit of 1 cent. Earnings, adjusted for one-time gains and costs, came to 60 cents per share.

The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 45 cents per share.

The drugmaker posted revenue of $13.28 billion in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $13.13 billion.

Pfizer expects full-year earnings in the range of $2.45 to $2.65 per share, with revenue in the range of $59.5 billion to $62.5 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PFE at https://www.zacks.com/ap/PFE